Literature DB >> 20009516

Conserved developmental alternative splicing of muscleblind-like (MBNL) transcripts regulates MBNL localization and activity.

Fulvia Terenzi1, Andrea N Ladd.   

Abstract

Muscleblind-like (MBNL) proteins have been shown to regulate pre-mRNA alternative splicing, and MBNL1 has been implicated in regulating fetal-to-adult transitions in alternative splicing in the heart. MBNL1 is highly conserved, exhibiting more than 95% identity at the amino acid level between birds and mammals. To investigate MBNL1 expression during embryonic heart development, we examined MBNL1 transcript and protein expression in the embryonic chicken heart from the formation of the primitive heart tube through cardiac morphogenesis (embryonic days 1.5 through 8). MBNL1 transcript levels remained steady throughout these stages, whereas MBNL1 protein levels increased and exhibited a shift in isoforms. MBNL1 has several alternatively spliced exons. Using RT-PCR, we determined that the inclusion of one of these, exon 5, decreases dramatically during cardiac morphogenesis. This developmental transition is conserved in mice. Functional analyses of MBNL1 isoforms containing or lacking exon 5-encoded sequences revealed that exon 5 is important for the regulation of the subcellular localization, RNA binding affinity, and alternative splicing activity of MBNL1 proteins. A second MBNL protein, MBNL2, is also expressed in the embryonic heart. We found that MBNL2 exon 5, which is paralogous to MBNL1 exon 5, is similarly regulated during embryonic heart development. Analysis of MBNL1 and MBNL2 transcripts in several embryonic tissues in chicken and mouse indicate that exon 5 alternative splicing is highly conserved and tissue-specific. Thus, we propose that conserved developmental stage- and tissue-specific alternative splicing of MBNL transcripts is an important mechanism by which MBNL activity is regulated during embryonic development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20009516     DOI: 10.4161/rna.7.1.10401

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  32 in total

1.  Autoregulated splicing of muscleblind-like 1 (MBNL1) Pre-mRNA.

Authors:  Devika P Gates; Leslie A Coonrod; J Andrew Berglund
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

2.  Mechanistic determinants of MBNL activity.

Authors:  Łukasz J Sznajder; Michał Michalak; Katarzyna Taylor; Piotr Cywoniuk; Michał Kabza; Agnieszka Wojtkowiak-Szlachcic; Magdalena Matłoka; Patryk Konieczny; Krzysztof Sobczak
Journal:  Nucleic Acids Res       Date:  2016-10-12       Impact factor: 16.971

3.  Muscleblind-like 1 (Mbnl1) regulates pre-mRNA alternative splicing during terminal erythropoiesis.

Authors:  Albert W Cheng; Jiahai Shi; Piu Wong; Katherine L Luo; Paula Trepman; Eric T Wang; Heejo Choi; Christopher B Burge; Harvey F Lodish
Journal:  Blood       Date:  2014-05-28       Impact factor: 22.113

4.  The transcriptional repressor BCL11A promotes breast cancer metastasis.

Authors:  Darcie D Seachrist; Molly M Hannigan; Natasha N Ingles; Bryan M Webb; Kristen L Weber-Bonk; Peng Yu; Gurkan Bebek; Salendra Singh; Steven T Sizemore; Vinay Varadan; Donny D Licatalosi; Ruth A Keri
Journal:  J Biol Chem       Date:  2020-06-23       Impact factor: 5.157

5.  Reactivation of fetal splicing programs in diabetic hearts is mediated by protein kinase C signaling.

Authors:  Sunil K Verma; Vaibhav Deshmukh; Patrick Liu; Curtis A Nutter; Rosario Espejo; Ming-Lung Hung; Guey-Shin Wang; Gene W Yeo; Muge N Kuyumcu-Martinez
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

6.  Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.

Authors:  Hélène Tran; Nathalie Gourrier; Camille Lemercier-Neuillet; Claire-Marie Dhaenens; Audrey Vautrin; Francisco José Fernandez-Gomez; Ludovic Arandel; Céline Carpentier; Hélène Obriot; Sabiha Eddarkaoui; Lucie Delattre; Edwige Van Brussels; Ian Holt; Glenn E Morris; Bernard Sablonnière; Luc Buée; Nicolas Charlet-Berguerand; Susanna Schraen-Maschke; Denis Furling; Isabelle Behm-Ansmant; Christiane Branlant; Marie-Laure Caillet-Boudin; Nicolas Sergeant
Journal:  J Biol Chem       Date:  2011-03-18       Impact factor: 5.157

Review 7.  Dynamic integration of splicing within gene regulatory pathways.

Authors:  Ulrich Braunschweig; Serge Gueroussov; Alex M Plocik; Brenton R Graveley; Benjamin J Blencowe
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

8.  Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.

Authors:  Yuanzheng Gao; Xiuming Guo; Katherine Santostefano; Yanlin Wang; Tammy Reid; Desmond Zeng; Naohiro Terada; Tetsuo Ashizawa; Guangbin Xia
Journal:  Mol Ther       Date:  2016-05-12       Impact factor: 11.454

9.  The zinc finger domains in U2AF26 and U2AF35 have diverse functionalities including a role in controlling translation.

Authors:  Olga Herdt; Stefan Reich; Jan Medenbach; Bernd Timmermann; Didrik Olofsson; Marco Preußner; Florian Heyd
Journal:  RNA Biol       Date:  2020-03-01       Impact factor: 4.652

Review 10.  RNA binding proteins in the regulation of heart development.

Authors:  Yotam Blech-Hermoni; Andrea N Ladd
Journal:  Int J Biochem Cell Biol       Date:  2013-08-20       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.